Advertisement

Topics

Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional Country Wise Analysis, Initiatives, Funding and 20 Company Profile Forecast to 2025 [Report Updated: 05032018

17:26 EDT 13 Mar 2018 | BioPortfolio Reports

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a noninvasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis detection, characterization of new lesions, drug therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.


The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for noninvasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement regulation scenario.


Global Liquid Biopsy Market Forecast by Circulating Biomarker


Based on circulating biomarkers, the global liquid biopsy market is being dominated by Circulating Tumor Cells CTCs.


The circulating tumor DNA ctDNA is the second largest segment of the liquid biopsy market.


The cell free DNA cfDNA is the third largest segment of the liquid biopsy market.


The extracellular vesicles EVs segment is the fastest growing segment during the forecast period.


Global Liquid Biopsy Market Forecast by Product


The global liquid biopsy market, by product, is being dominated by Kits and Consumables.


The instruments segment is likely to witness highest growth in the global liquid biopsy market.


The services segment captured least share of the liquid biopsy market.


Global Liquid Biopsy Market Forecast by Application


The global liquid biopsy market, by application, is being dominated by oncology application.


Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.


The noncancer application segment is expected to be the fastestgrowing segment in the market during the forecast period.


Global Liquid Biopsy Oncology Market Forecast by Clinical Application


On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecasting period.


Treatment monitoring captured second highest share of the liquid biopsy market in 2017, being followed by the early cancer screening application.


Recurrence monitoring captured least share of the liquid biopsy market.


Global Liquid Biopsy Market Forecast by End User


In 2017, Reference laboratories captured largest share of the global liquid biopsy market.


Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2017, being followed by Academic and Research Centers.



Global Liquid Biopsy Market Forecast by Sample Type


Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.


The urine sample segment is anticipated to witness noticeable growth throughout the forecasting period.



Liquid Biopsy Market Forecast Regional Analysis


North America accounted for largest share of the global liquid biopsy market in 2017, followed by Europe.


In North America, United States accounted for largest share of the liquid biopsy market.


In Europe, Germany and France are the leading market for liquid biopsy.


Asia pacific is likely to be the fastest growing market for liquid biopsy during the forecasting period.


In Asia Pacific, Japan and China are the leading market for liquid biopsy.


Latin America is the fourth largest market for liquid biopsy, being followed by Middle East Africa.


iGATE RESEARCH report titled Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional Country Wise Analysis, Initiatives, Funding and 20 Company Profile Forecast to 2025 provides a comprehensive assessment of the fastevolving, highgrowth Global Liquid Biopsy Market.


This 305 Page report with 118 Figures and 7 Tables has been analyzed from 15 viewpoints:


1. Global Liquid Biopsy Market Forecast 2015 2025

2. Global Liquid Biopsy Market Share Forecast 2015 2025

3. Global Liquid Biopsy Market Forecast by Circulating Biomarker 2015 2025

4. Global Liquid Biopsy Market Forecast by Product 2015 2025

5. Global Liquid Biopsy Market Forecast by Application 2015 2025

6. Global Liquid Biopsy Oncology Market Forecast By Cancer Types 2015 2025

7. Global Liquid Biopsy Oncology Market Forecast by Clinical Application 2015 2025

8. Global Liquid Biopsy Market Forecast by End User 2015 2025

9. Global Liquid Biopsy Market Forecast by Sample Type 2015 2025

10. Liquid Biopsy Market Forecast Regional Analysis 2015 2025

11. Liquid Biopsy Market Share Forecast Geographical Analysis 2015 2025

12. Liquid Biopsy Initiatives

13. Liquid Biopsy Companies Financing Details

14. 20 Company Profiles

15. Global Liquid Biopsy Market Driving Factors Challenges


Global Liquid Biopsy Market Forecast by Circulating Biomarker 2015 2025


1. Circulating Tumor Cells CTCs

2. Circulating Tumor DNA ctDNA

3. CellFree DNA cfDNA

4. Extracellular Vesicles EVs

5. Other Circulating Biomarkers


Global Liquid Biopsy Market Forecast by Product 2015 2025


1. Kits and Consumables

2. Instruments

3. Services


Global Liquid Biopsy Market Forecast by Application 2015 2025


1. Oncology Application


Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Gastrointestinal Cancer

Leukaemia

Others


2. NonCancer Application


Global Liquid Biopsy Oncology Market Forecast by Clinical Application 2015 2025


1. Therapy Selection

2. Treatment Monitoring

3. Early Cancer Screening

4. Recurrence Monitoring


Global Liquid Biopsy Market Forecast by End User 2015 2025


1. Reference Laboratories

2. Hospitals and Physician Laboratories

3. Academic and Research Centers

4. Other End Users


Global Liquid Biopsy Market Forecast by Sample Type 2015 2025


1. Blood Sample

2. Urine Sample

3. Other Fluids Sample


Liquid Biopsy Market Forecast Regional Analysis 2015 2025


1. North America


United States

Canada


2. Asia Pacific


South Korea

Japan

China

India

Australia

Rest of Asia Pacific


3. Europe


Germany

France

United Kingdom

Italy

Spain

Rest of Europe


4. Middle East Africa


UAE

Saudi Arabia

Egypt

Rest of Middle East Africa


5. Latin America


Liquid Biopsy Market Company Profiles


1. Personal Genome Diagnostics

2. Guardant Health, Inc.

3. Pathway Genomics

4. RainDance Technologies Acquired by BioRad Laboratories, Inc.

5. Trovagene, Inc

6. Cynvenio Biosystems, Inc.

7. Biocept, Inc.

8. ANGLE plc

9. MDxHealth

10. Clearbridge BioMedics Pte Ltd

11. Exosome Diagnostics, Inc

12. Foundation Medicine, Inc

13. Roche Diagnostics A Subsidiary of F. HoffmannLa Roche AG

14. Genomic Health

15. Myriad Genetics, Inc

16. Thermo Fisher Scientific, Inc

17. QIAGEN NV

18. BioRad Laboratories, Inc

19. MenariniSilicon Biosystems

20. GRAIL



Data Sources


iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.


Research Methodologies


Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.


Secondary Research Methodologies: Printable and Nonprintable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Original Article: Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional Country Wise Analysis, Initiatives, Funding and 20 Company Profile Forecast to 2025 [Report Updated: 05032018

NEXT ARTICLE

More From BioPortfolio on "Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional Country Wise Analysis, Initiatives, Funding and 20 Company Profile Forecast to 2025 [Report Updated: 05032018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...